Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4923-4932
Author(s):
W. Li, L. Du and M. Li
Anticancer Metallotherapeutics in Preclinical Development
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4738-4752
Author(s):
G. N. Kaluderovic and R. Paschke
Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies
Journal:
Current Molecular Medicine
Volume:
11
Page:
623-632
Author(s):
I. Zachos, V. Tzortzis, P. A. Konstantinopoulos, A. Karatzas, S. Gravas, M. Melekos and A. G. Papavassiliou
Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Journal:
Current Diabetes Reviews
Volume:
7
Page:
392-405
Author(s):
Samer El-Kaissi and Suphia Sherbeeni
The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Journal:
Current Cancer Therapy Reviews
Volume:
7
Page:
267-271
Author(s):
Alan M. Nieder, Jeetu Nebhnani and Fernando J. Bianco
Sphingolipid Signaling and Hematopoietic Malignancies: To the Rheostat and Beyond
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
782-793
Author(s):
Kenneth C. Loh, Dianna Baldwin and Julie D. Saba
Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
830-843
Author(s):
Gemma Fabrias, Carmen Bedia, Josefina Casas, Jose Luis Abad and Antonio Delgado
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1005-1024
Author(s):
K. Podar and K. C. Anderson
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1082-1097
Author(s):
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan
Prodrugs in Photodynamic Anticancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3548-3559
Author(s):
Robert Musiol, Maciej Serda and Jaroslaw Polanski